Cited by 391PARP inhibition in cancer therapyDNA Repair MechanismsBRCA gene mutations in cancer

The DOI matches its Crossref record; 551 of the 559 references it cites were found in a registry or an index.

Therapeutic applications of PARP inhibitors: Anticancer therapy and beyond

Open access

Curtin, Nicola J., Szabo, Csaba·2013·Molecular Aspects of Medicine

DOI 10.1016/j.mam.2013.01.006PMC PMC3657315

Open this paper in CoChat — free account

Abstract

The aim of this article is to describe the current and potential clinical translation of pharmacological inhibitors of poly(ADP-ribose) polymerase (PARP) for the therapy of various diseases. The first section of the present review summarizes the available preclinical and clinical data with PARP inhibitors in various forms of cancer. In this context, the role of PARP in single-strand DNA break repair is relevant, leading to replication-associated lesions that cannot be repaired if homologous recombination repair (HRR) is defective, and the synthetic lethality of PARP inhibitors in HRR-defective cancer. HRR defects are classically associated with BRCA1 and 2 mutations associated with familial breast and ovarian cancer, but there may be many other causes of HRR defects. Thus, PARP inhibitors may be the drugs of choice for BRCA mutant breast and ovarian cancers, and extend beyond these tumors if appropriate biomarkers can be developed to identify HRR defects. Multiple lines of preclinical data demonstrate that PARP inhibition increases cytotoxicity and tumor growth delay in combination with temozolomide, topoisomerase inhibitors and ionizing radiation. Both single agent and combination clinical trials are underway. The final part of the first section of the present review summarizes the current status of the various PARP inhibitors that are in various stages of clinical development. The second section of the present review summarizes the role of PARP in selected non-oncologic indications. In a number of severe, acute diseases (such as stroke, neurotrauma, circulatory shock and acute myocardial infarction) the clinical translatability of PARP inhibition is supported by multiple lines of preclinical data, as well as observational data demonstrating PARP activation in human tissue samples. In these disease indications, PARP overactivation due to oxidative and nitrative stress drives cell necrosis and pro-inflammatory gene expression, which contributes to disease pathology. Accordingly, multiple lines of preclinical data indicate the efficacy of PARP inhibitors to preserve viable tissue and to down-regulate inflammatory responses. As the clinical trials with PARP inhibitors in various forms of cancer progress, it is hoped that a second line of clinical investigations, aimed at testing of PARP inhibitors for various non-oncologic indications, will be initiated, as well.

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Integrity signals

Registry

Crossref · 10.1016/j.mam.2013.01.006

Cites

551 of 551 references verified0 citation errors · 0 not checkable

Statistics

Claims the paper makes

The claims and statistics of this paper haven’t been checked yet.

Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.

Claims other papers make about this one

Each is checked against this paper’s own text: does it say what the citing paper says it does?

Self-check

Percentages, sums and reported differences re-computed from the paper’s own numbers.

The self-check needs the paper’s full text.

1 retracted

Items 401–551 of 551

Reduction of myocardial reperfusion injury by an inhibitor of poly (ADP-ribose) synthetase in the pig
Bowes, J., Ruetten, H., Martorana, P. A., Stockhausen, H., & Thiemermann, C. (1998) · European Journal of Pharmacology · doi:10.1016/s0014-2999(98)00638-4 · Cited by 46
Poly(ADP-ribose) polymerase: a new therapeutic target?
Gerő, D., & Szabó, C. (2008) · Current Opinion in Anaesthesiology · doi:10.1097/aco.0b013e3282f63c15 · Cited by 46
Poly(ADP-ribosyl)ation in asthma and other lung diseases
Virág, L. (2005) · Pharmacological Research · doi:10.1016/j.phrs.2005.02.012 · Cited by 46
A poly(ADP‐ribose) polymerase haplotype spanning the promoter region confers susceptibility to rheumatoid arthritis
Pascual, M., López‐Nevot, M. Á., Cáliz, R., Ferrer, M. A., Balsa, A., Pascual‐Salcedo, D., & Martin, J. J. (2003) · Arthritis & Rheumatism · doi:10.1002/art.10864 · Cited by 46
INO-1001, a novel inhibitor of poly(ADP-ribose) polymerase, enhances tumor response to doxorubicin
Mason, K. A., Valdecanas, D. R., Hunter, N. R., & Milas, L. (2007) · Investigational New Drugs · doi:10.1007/s10637-007-9072-5 · Cited by 46
The significance of antibodies to poly(adenosine diphosphate-ribose) in systemic lupus erythematosus.
Okolie, E. E., & Shall, S. (1979) · PubMed · Cited by 45
The differential response of human tumours to fractionated radiation may be due to a post-irradiation repair process
Weichselbaum, R. R., & Little, J. B. (1982) · British Journal of Cancer · doi:10.1038/bjc.1982.237 · Cited by 45
Prevention of Endotoxin-Induced Lethality, but Not of Liver Apoptosis in Poly(ADP-ribose) Polymerase-Deficient Mice
Kühnle, S., Nicotera, P., Wendel, A., & Leist, M. (1999) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1999.1393 · Cited by 45
Poly (ADP-ribose) Polymerase-1–Inhibiting Flavonoids Attenuate Cytokine Release in Blood from Male Patients with Chronic Obstructive Pulmonary Disease or Type 2 Diabetes
Weseler, A. R., Geraets, L., Moonen, H. J. J., MANDERS, R. J. F., van Loon, L. J. C., Pennings, H.-J., Wouters, E. F. �., Bast, A., & Hageman, G. J. (2009) · Journal of Nutrition · doi:10.3945/jn.108.102756 · Cited by 45
Poly(ADP-ribose)polymerase inhibition counteracts renal hypertrophy and multiple manifestations of peripheral neuropathy in diabetic Akita mice
Obrosova, I. (2011) · International Journal of Molecular Medicine · doi:10.3892/ijmm.2011.709 · Cited by 44
Metallothionein protects against doxorubicin-induced cardiomyopathy through inhibition of superoxide generation and related nitrosative impairment
Shuai, Y., Guo, J., Peng, S., Zhang, L., Guo, J. F., Han, G., & Dong, Y. (2007) · Toxicology Letters · doi:10.1016/j.toxlet.2007.02.010 · Cited by 44
Polyunsaturated Fatty Acids, DNA Repair Single Nucleotide Polymorphisms and Colorectal Cancer in the Singapore Chinese Health Study
Stern, M. C., Butler, L. M., Corral, R., Joshi, A. D., Yuan, J., Koh, W., & Yu, M. C. (2009) · Lifestyle Genomics · doi:10.1159/000308467 · Cited by 43
Poly(ADP‐ribose)polymerase inhibitor can attenuate the neuronal death after 1‐methyl‐4‐phenyl‐1,2,3,6‐tetrahydropyridine‐induced neurotoxicity in mice
Yokoyama, H., Kuroiwa, H., Tsukada, T., Uchida, H., Kato, H., & Araki, T. (2009) · Journal of Neuroscience Research · doi:10.1002/jnr.22310 · Cited by 43
Reciprocal regulation of iNOS and PARP-1 during allergen-induced eosinophilia
Naura, A. S., Datta, R., Hans, C. P., Zerfaoui, M., Rezk, B. M., Errami, Y., Oumouna, M., Matrougui, K., & Boulares, A. H. (2008) · European Respiratory Journal · doi:10.1183/09031936.00089008 · Cited by 43
THE PARP-1 INHIBITOR INO-1001 FACILITATES HEMODYNAMIC STABILIZATION WITHOUT AFFECTING DNA REPAIR IN PORCINE THORACIC AORTIC CROSS-CLAMPING-INDUCED ISCHEMIA/REPERFUSION
Hauser, B. Z., Gr??ger, M., Ehrmann, U., Albicini, M., ckner, U. B. B., Schelzig, H., Venkatesh, B., Li, H., Szabó, C., Speit, G., et al. (2006) · Shock · doi:10.1097/01.shk.0000209561.61951.2e · Cited by 42
Restoration of the endothelial function in the aortic rings of apolipoprotein E deficient mice by pharmacological inhibition of the nuclear enzyme poly(ADP-ribose) polymerase
Benkő, R., Pacher, P., Vaslin, A., Kollai, M., & Szabó, C. (2004) · Life Sciences · doi:10.1016/j.lfs.2004.04.007 · Cited by 42
Post‐allergen challenge inhibition of poly(ADP‐ribose) polymerase harbors therapeutic potential for treatment of allergic airway inflammation
Naura, A. S., Hans, C. P., Zerfaoui, M., You, D., Cormier, S. A., Oumouna, M., & Boulares, A. H. (2008) · Clinical & Experimental Allergy · doi:10.1111/j.1365-2222.2008.02943.x · Cited by 42
Activation of poly(ADP-ribose) polymerase by myocardial ischemia and coronary reperfusion in human circulating leukocytes.
Tóth-Zsámboki, E., Horvath, E. M., Vargová, K., et al. (2007) · PubMed · doi:10.2119/2006–00055.toth-zsamboki · Cited by 41
Nitrative stress and poly(ADP-ribose) polymerase activation in healthy and gestational diabetic pregnancies
Horvath, E. M., Mágenheim, R., Kugler, E., Vácz, G., Szigethy, A., Lévárdi, F., Kollai, M., Szabó, C., & Lacza, Z. (2009) · Diabetologia · doi:10.1007/s00125-009-1435-3 · Cited by 41
Interaction between Poly(ADP-Ribose) Polymerase 1 and Interleukin 1A Genes Is Associated with Alzheimer’s Disease Risk
Infante, J., Llorca, J., Mateo, I., Rodríguez‐Rodríguez, E., Sánchez‐Quintana, C., Sánchez‐Juan, P., Fernández‐Viadero, C., Peña, N., Berciano, J., & Combarros, O. (2007) · Dementia and Geriatric Cognitive Disorders · doi:10.1159/000099471 · Cited by 41
Role of peroxynitrite and activation of poly (ADP‐ribose) synthetase in the vascular failure induced by zymosan‐activated plasma
Cuzzocrea, S., Zingarelli, B., O'Connor, M., Salzman, A. L., Caputi, A. P., & Szabó, C. (1997) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0701387 · Cited by 41
Influence of PARP-1 Polymorphisms in Patients after Traumatic Brain Injury
Sarnaik, A., Conley, Y. P., Okonkwo, D. O., Barr, T. L., Fink, E. L., Szabó, C., Kochanek, P. M., & Clark, R. S. B. (2009) · Journal of Neurotrauma · doi:10.1089/neu.2009.1171 · Cited by 41
EFFECTS OF INHIBITORS OF POLY(ADP-RIBOSE) SYNTHETASE ACTIVITY ON HYPOTENSION AND MULTIPLE ORGAN DYSFUNCTION CAUSED BY ENDOTOXIN
Wray, G. M., Hinds, C., & Thiemermann, C. (1998) · Shock · doi:10.1097/00024382-199807000-00003 · Cited by 41
A New Poly(ADP-Ribose) Polymerase Inhibitor, FR261529 [2-(4-Chlorophenyl)-5-quinoxalinecarboxamide], Ameliorates Methamphetamine-Induced Dopaminergic Neurotoxicity in Mice
Iwashita, A., Mihara, K., Yamazaki, S., Matsuura, S., Ishida, J., Yamamoto, H., Hattori, K., Matsuoka, N., & Mutoh, S. (2004) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.104.068932 · Cited by 41
Inflammatory and transcriptional roles of poly (ADP-ribose) polymerase in ventilator-induced lung injury
Kim, J. H., Suk, M. H., Yoon, D. W., Kim, H. Y., Jung, K. H., Kang, E. H., Lee, S. Y., Lee, S. Y., Suh, I. B., Shin, C., et al. (2008) · Critical Care · doi:10.1186/cc6995 · Cited by 41
The Septic Shock-Associated IL-10 −1082 A > G Polymorphism Mediates Allele-Specific Transcription via Poly(ADP-Ribose) Polymerase 1 in Macrophages Engulfing Apoptotic Cells
Kang, X., Kim, H.-J., Ramírez, M., Salameh, S., & Ma, X. (2010) · The Journal of Immunology · doi:10.4049/jimmunol.0903613 · Cited by 40
Poly (ADP-Ribose) Polymerase Inhibition Prevents Spontaneous and Recurrent Autoimmune Diabetes in NOD Mice by Inducing Apoptosis of Islet-Infiltrating Leukocytes
Suarez‐Pinzon, W. L., Mabley, J. G., Power, R. F., Szabó, C., & Rabinovitch, A. (2003) · Diabetes · doi:10.2337/diabetes.52.7.1683 · Cited by 40
Poly(ADP-ribose) polymerase-1 (PARP-1) gene deficiency alleviates diabetic kidney disease
Shevalye, H., Maksimchyk, Y., Watcho, P., & Obrosova, I. G. (2010) · Biochimica et Biophysica Acta (BBA) - Molecular Basis of Disease · doi:10.1016/j.bbadis.2010.07.004 · Cited by 40
Effects of a Potent Peroxynitrite Decomposition Catalyst in Murine Models of Endotoxemia and Sepsis
Soriano, F. G., Lorigados, C. B., Pacher, P., & Szabó, C. (2011) · Shock · doi:10.1097/shk.0b013e31820fe5d5 · Cited by 39
Activation of poly(ADP-ribose) polymerase in severe hemorrhagic shock and resuscitation
Watts, J. A., Grattan, R. M., Whitlow, B. S., & Kline, J. A. (2001) · American Journal of Physiology-Gastrointestinal and Liver Physiology · doi:10.1152/ajpgi.2001.281.2.g498 · Cited by 39
Therapeutic treatment with poly(ADP‐ribose) polymerase inhibitors attenuates the severity of acute pancreatitis and associated liver and lung injury
Mota, R., Bueno, F. S., Berenguer-Pina, J. J., Hernández‐Espinosa, D., Parrilla, P., & Yélamos, J. (2007) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0707310 · Cited by 38
Effects of 3-aminobenzamide, an inhibitor of poly (ADP-ribose) polymerase, in a mouse model of acute pancreatitis induced by cerulein
Mazzon, E., Genovese, T., Paola, R. D., Muià, C., Crisafulli, C., Malleo, G., Esposito, E., Meli, R., Sessa, E., & Cuzzocrea, S. (2006) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2006.08.008 · Cited by 38
Therapeutic window for nicotinamide following transient focal cerebral ischemia
Ayoub, I. A., & Maynard, K. I. (2002) · Neuroreport · doi:10.1097/00001756-200202110-00008 · Cited by 38
Role of poly-(ADP-ribose) synthetase in lipopolysaccharide-induced vascular failure and acute lung injury in pigs
Albertini, M., Clement, M. G., Lafortuna, C. L., Caniatti, M., Magder, S. A., Abdulmalek, K., & Hussain, S. N. A. (2000) · Journal of Critical Care · doi:10.1053/jcrc.2000.7903 · Cited by 37
Poly (ADP-ribose) polymerase-1 initiated neuronal cell death pathway—do androgens matter?
Vagnerova, K., Liu, K., Ardeshiri, A., Cheng, J., Murphy, S. J., Hurn, P. D., & Herson, P. S. (2009) · Neuroscience · doi:10.1016/j.neuroscience.2009.12.041 · Cited by 37
Poly (ADP-Ribose) Polymerase-1 (PARP-1) as Immune Regulator
Laudisi, F., Sambucci, M., & Pioli, C. (2011) · Endocrine Metabolic & Immune Disorders - Drug Targets · doi:10.2174/187153011797881184 · Cited by 37
A ltered A utoantigen S tructure in S j ö gren ’ s S yndrome: I mplications for the P athogenesis of A utoimmune T issue D amage
Rosen, A., & Casciola-Rosen, L. A. (2004) · Critical Reviews in Oral Biology & Medicine · doi:10.1177/154411130401500304 · Cited by 37
Poly(ADP-Ribose) Polymerase Inhibition Improves Postischemic Myocardial Function After Cardioplegia-Cardiopulmonary Bypass
Khan, T., Ruel, M., Bianchi, C. F., Voisine, P., Komjáti, K., Szabó, C., & Sellke, F. W. (2003) · Journal of the American College of Surgeons · doi:10.1016/s1072-7515(03)00538-6 · Cited by 37
Phase II trial of the poly(ADP-ribose) polymerase (PARP) inhibitor AG-014699 in BRCA 1 and 2–mutated, advanced ovarian and/or locally advanced or metastatic breast cancer.
Drew, Y., Ledermann, J. A., Jones, A. L., Hall, G. D., Jayson, G. C., Highley, M., Rea, D., Glasspool, R. M., Halford, S. E. R., Crosswell, G., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.29.15_suppl.3104 · Cited by 37
Self-citation
Effects of PD 128763, a New Potent Inhibitor of Poly(ADP-Ribose) Polymerase, on X-Ray-Induced Cellular Recovery Processes in Chinese Hamster V79 Cells
Arundel-Suto, C. M., Scavone, S. V., Turner, W. R., Suto, M. J., & Sebolt, J. S. (1991) · Radiation Research · doi:10.2307/3577927 · Cited by 37
Analysis of genetic variants of the poly(ADP-ribose) polymerase-1 gene in breast cancer in French patients
Cao, W., Wang, X., Frappart, L., Rigal, D., Wang, Z., Shen, Y., & Tong, W. (2007) · Mutation Research/Genetic Toxicology and Environmental Mutagenesis · doi:10.1016/j.mrgentox.2007.04.011 · Cited by 36
Time Profile of Oxidative Stress and Neutrophil Activation in Ovine Acute Lung Injury and Sepsis
Lange, M., Szabó, C., Traber, D. L., Horvath, E. M., Hamahata, A., Nakano, Y. Y., Traber, L. D., Cox, R. A., Schmalstieg, F. C., Herndon, D. N., et al. (2012) · Shock · doi:10.1097/shk.0b013e31824b1793 · Cited by 36
3-AMINOBENZAMIDE, AN INHIBITOR OF POLY (ADP-RIBOSE) SYNTHETASE, IMPROVES HEMODYNAMICS AND PROLONGS SURVIVAL IN A PORCINE MODEL OF HEMORRHAGIC SHOCK
Szabó, A., Hake, P. W., Salzman, A. L., & Szabó, C. (1998) · Shock · doi:10.1097/00024382-199811000-00007 · Cited by 36
Poly (ADP-ribose) polymerase-1 (PARP-1) genetic variants are protective against Parkinson's disease
Infante, J., Sánchez‐Juan, P., Mateo, I., Rodríguez‐Rodríguez, E., Sánchez‐Quintana, C., Llorca, J., Fontalba, A., Terrazas, J. M., Oterino, A., Berciano, J., et al. (2007) · Journal of the Neurological Sciences · doi:10.1016/j.jns.2007.02.008 · Cited by 36
Effect of 6(5H)-phenanthridinone, a poly (ADP-ribose)polymerase inhibitor, and ionizing radiation on the growth of cultured lymphoma cells
Weltin, D. (1997) · International Journal of Radiation Biology · doi:10.1080/095530097142843 · Cited by 36
The radiosensitizer nicotinamide inhibits arterial vasoconstriction
Hirst, D. G., Kennovin, G. D., & Flitney, F. W. (1994) · British Journal of Radiology · doi:10.1259/0007-1285-67-800-795 · Cited by 36
PARP-1 Deficiency Increases the Severity of Disease in a Mouse Model of Multiple Sclerosis
Selvaraj, V., Soundarapandian, M. M., Chechneva, O. V., Williams, A. J., Sidorov, M. K., Soulika, A. M., Pleasure, D., & Deng, W. (2009) · Journal of Biological Chemistry · doi:10.1074/jbc.m109.013474 · Cited by 35
Poly(ADP-ribose) polymerase (PARP) polymorphisms associated with nephritis and arthritis in systemic lupus erythematosus
Hur, J.-W., Sung, Y., Shin, H. D., Park, B. L., Cheong, H. S., & Bae, S. (2006) · Lara D. Veeken · doi:10.1093/rheumatology/kei262 · Cited by 35
Changes in topoisomerase I levels and localization during myeloid maturation in vitro and in vivo.
Kaufmann, S. H., Charron, M., Burke, P. J., & Karp, J. E. (1995) · PubMed · Cited by 34
Distinct Production of Autoantibodies to Nuclear Components in Ulcerative Colitis and in Crohn's Disease
Reumaux, D., Mézière, C., Colombel, J., Duthilleul, P., & Muller, S. (1995) · Clinical Immunology and Immunopathology · doi:10.1006/clin.1995.1162 · Cited by 34
Polymorphisms of ADPRT Val762Ala and XRCC1 Arg399Glu and risk of breast cancer in Chinese women: A case control analysis
Zhai, X., Liu, J., Hu, Z., Wang, S., Qing, J.-W., Wang, X., Jin, G., Gao, J., Wang, X., & Shen, H. (2006) · Oncology Reports · doi:10.3892/or.15.1.247 · Cited by 34
Poly(ADP-ribose) polymerase-1 (PARP-1) controls lung cell proliferation and repair after hyperoxia-induced lung damage
Pagano, A., Ruchonnet-Métrailler, I., Aurrand‐Lions, M., Lucattelli, M., Donati, Y. R. A., & Argiroffo, C. B. (2007) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00037.2007 · Cited by 34
Acute myocardial infarction induced increases in plasma tumor necrosis factor-α and interleukin-10 are associated with the activation of poly(ADP-ribose) polymerase of circulating mononuclear cell
Yao, L., Huang, K., Huang, D., Wang, J., Guo, H.-P., & Yuhua, L. (2007) · International Journal of Cardiology · doi:10.1016/j.ijcard.2007.06.069 · Cited by 33
Renal hypoperfusion and impaired endothelium-dependent vasodilation in an animal model of VILI: the role of the peroxynitrite-PARP pathway
Vaschetto, R., Kuiper, J. W., Musters, R. J. P., Eringa, E. C., Corte, F. D., Murthy, K. G. K., Groeneveld, A. B. J., & Plötz, F. B. (2010) · Critical Care · doi:10.1186/cc8932 · Cited by 33
Identification of agents that reduce renal hypoxia–reoxygenation injury using cell-based screening: Purine nucleosides are alternative energy sources in LLC-PK1 cells during hypoxia
Szoleczky, P., Módis, K., Nagy, N., Tóth, Z. D., DeWitt, D. S., Szabó, C., & Gerő, D. (2011) · Archives of Biochemistry and Biophysics · doi:10.1016/j.abb.2011.11.005 · Cited by 33
Cardiomyocyte death in patients with end-stage heart failure before and after support with a left ventricular assist device: low incidence of apoptosis despite ubiquitous mediators
de Jonge, N., van Wichen, D. F., van Kuik, J., Kirkels, H., Lahpor, J. R., Gmelig-Meyling, F. H. J., van den Tweel, J. G., & de Weger, R. A. (2003) · The Journal of Heart and Lung Transplantation · doi:10.1016/s1053-2498(02)01160-9 · Cited by 33
Poly(ADP-ribose) polymerase inhibitor is neuroprotective in epileptic rat via apoptosis-inducing factor and Akt signaling
Wang, S., Wang, S., Song, Z., Liu, X.-W., Wang, R., & Zhao-fu, C. (2007) · Neuroreport · doi:10.1097/wnr.0b013e32826fb3a5 · Cited by 32
Combination effects of poly(ADP-ribose) polymerase inhibitors and DNA-damaging agents in ovarian tumor cell lines ?with special reference to cisplatin
Bernges, F., & Zeller, W. J. (1996) · Journal of Cancer Research and Clinical Oncology · doi:10.1007/bf01209029 · Cited by 31
Identification of autoantibody against poly (ADP-ribose) polymerase (PARP) fragment as a serological marker in systemic lupus erythematosus
Jeoung, D., Lim, Y., Lee, E. B., Lee, S., Kim, H., Lee, H., & Song, Y. W. (2003) · Journal of Autoimmunity · doi:10.1016/j.jaut.2003.10.009 · Cited by 31
Effect of Acute Poly(ADP-Ribose) Polymerase Inhibition by 3-AB on Blood–Brain Barrier Permeability and Edema Formation after Focal Traumatic Brain Injury in Rats
Lescot, T., Fulla-Oller, L., Palmier, B., Po, C., Béziaud, T., Puybasset, L., Plotkine, M., Gillet, B., Méric, P., & Marchand‐Leroux, C. (2010) · Journal of Neurotrauma · doi:10.1089/neu.2009.1188 · Cited by 31
Treatment with insulin inhibits poly(ADP-ribose)polymerase activation in a rat model of endotoxemia
Horvath, E. M., Benkő, R., Gerő, D., Kiss, L., & Szabó, C. (2007) · Life Sciences · doi:10.1016/j.lfs.2007.11.001 · Cited by 30
PARP inhibition improves the effectiveness of neural stem cell transplantation in experimental brain trauma
Lacza, Z., Horvath, E. M., Komjáti, K., Hortobágyi, T., Szabó, C., & Busija, D. W. (2003) · International Journal of Molecular Medicine · doi:10.3892/ijmm.12.2.153 · Cited by 30
Oxidant-induced cardiomyocyte injury: Identification of the cytoprotective effect of a dopamine 1 receptor agonist using a cell-based high-throughput assay
Szabó, C., Dormán, G., Tóth, Z., Nagy, N., Szoleczky, P., Módis, K., & Gerő, D. (2007) · International Journal of Molecular Medicine · doi:10.3892/ijmm.20.5.749 · Cited by 30
POLY(ADENOSINE DIPHOSPHATE-RIBOSE) POLYMERASE INHIBITION PRESERVES ERECTILE FUNCTION IN RATS AFTER CAVERNOUS NERVE INJURY
Kendirci, M., Zsengellér, Z. K., Bivalacqua, T. J., Gür, S., Usta, M. F., CHEN, M., Szabó, C., & Hellstrom, W. J. G. (2005) · The Journal of Urology · doi:10.1097/01.ju.0000176484.35636.e5 · Cited by 30
Peroxynitrite decomposition catalyst, FP15, and poly(ADP-ribose) polymerase inhibitor, PJ34, inhibit leukocyte entrapment in the retinal microcirculation of diabetic rats
Sugawara, R., Hikichi, T., Kitaya, N., Mori, F., Nagaoka, T., Yoshida, A., & Szabó, C. (2004) · Current Eye Research · doi:10.1080/02713680490513146 · Cited by 30
Clinical Neuroprotective Drugs for Treatment and Prevention of Stroke
Kikuchi, K., Uchikado, H., Morioka, M., Murai, Y., & Tanaka, E. (2012) · International Journal of Molecular Sciences · doi:10.3390/ijms13067739 · Cited by 30
PARP-1 Val762Ala Polymorphism Is Associated with Risk of Cervical Carcinoma
Ye, F., Cheng, Q., Hu, Y., Zhang, J., & Chen, H. (2012) · PLoS ONE · doi:10.1371/journal.pone.0037446 · Cited by 30
Does PTEN Loss Impair DNA Double-Strand Break Repair by Homologous Recombination?
Hunt, C. R., Gupta, A. K. D., Horikoshi, N., & Pandita, T. K. (2011) · Clinical Cancer Research · doi:10.1158/1078-0432.ccr-11-3131 · Cited by 30
Combined therapy with PJ34, a poly(ADP‐ribose)polymerase inhibitor, reduces tissue plasminogen activator‐induced hemorrhagic transformations in cerebral ischemia in mice
Haddad, M., Beray‐Berthat, V., Coqueran, B., Plotkine, M., Marchand‐Leroux, C., & Margaill, I. (2012) · Fundamental and Clinical Pharmacology · doi:10.1111/j.1472-8206.2012.01036.x · Cited by 29
Targeting poly(ADP-ribose) polymerase-1 as a promising approach for immunomodulation in multiple sclerosis?
Cavone, L., & Chiarugi, A. (2011) · Trends in Molecular Medicine · doi:10.1016/j.molmed.2011.10.002 · Cited by 29
Poly(adenosine diphosphate—ribose) polymerase expression in human traumatic brain injury
Ang, B. T., Yap, E., Lim, J., Tan, W. L., Ng, P. Y., Ng, I., & Yeo, T. T. (2003) · Journal of neurosurgery · doi:10.3171/jns.2003.99.1.0125 · Cited by 29
Effect of L-2286, a Poly(ADP-ribose)polymerase Inhibitor and Enalapril on Myocardial Remodeling and Heart Failure
Bartha, É., Kiss, G. N., Kálmán, E., Kulcsár, G., Kálai, T., Hideg, K., Habon, T., Sümegi, B., Tóth, K., & Halmosi, R. (2008) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e3181855cef · Cited by 28
THERAPEUTIC INJECTION OF PARP INHIBITOR INO-1001 PRESERVES CARDIAC FUNCTION IN PORCINE MYOCARDIAL ISCHEMIA AND REPERFUSION WITHOUT REDUCING INFARCT SIZE
Roesner, J. P., Mersmann, J., Bergt, S., Bohnenberg, K., Barthuber, C., Szabó, C., Nöldge-Schomburg, G. E. F., & Zacharowski, K. D. (2010) · Shock · doi:10.1097/shk.0b013e3181c4fb08 · Cited by 28
Differential expression in lupus-associated IL-10 promoter single-nucleotide polymorphisms is mediated by poly(ADP-ribose) polymerase-1
Chung, E. Y., Liu, J., Zhang, Y., & Ma, X. (2007) · Genes and Immunity · doi:10.1038/sj.gene.6364420 · Cited by 28
Regulation of Kinase Cascade Activation and Heat Shock Protein Expression by Poly(ADP-ribose) Polymerase Inhibition in Doxorubicin-induced Heart Failure
Bartha, É., Solti, I., Szabó, A., Oláh, G., Magyar, K., Szabados, E., Kálai, T., Hideg, K., Tóth, K., Gerő, D., et al. (2011) · Journal of Cardiovascular Pharmacology · doi:10.1097/fjc.0b013e318225c21e · Cited by 28
Autoantibodies to Poly(ADP-Ribose)Polymerase in Autoimmune Diseases
Negri, C., Scovassi, A. I., Cerino, A., Negroni, M., Borzı̀, R. M., Melicòni, R., Facchini, A., Montecucco, C., & Ricotti, G. C. B. A. (1990) · Autoimmunity · doi:10.3109/08916939009041040 · Cited by 28
Treatment with PARP-1 inhibitors, GPI 15427 or GPI 16539, ameliorates intestinal damage in rat models of colitis and shock
Paola, R. D., Mazzon, E., Xu, W., Genovese, T., Ferrraris, D., Muià, C., Crisafulli, C., Zhang, J., & Cuzzocrea, S. (2005) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2005.09.055 · Cited by 27
Effects of inhibitors of the activity of poly (ADP‐ribose) synthetase on the organ injury and dysfunction caused by haemorrhagic shock
McDonald, M. C., Mota‐Filipe, H., & Thiemermann, C. (1999) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0702928 · Cited by 27
Phase I study of the safety, pharmacokinetics (PK), and pharmacodynamics (PD) of the poly(ADP-ribose) polymerase (PARP) inhibitor veliparib (ABT-888; V) in combination with irinotecan (CPT-11; Ir) in patients (pts) with advanced solid tumors.
LoRusso, P. M., Ji, J., Li, J., Heilbrun, L. K., Shapiro, G. I., Sausville, E. A., Boerner, S. A., Smith, D. W., Pilat, M. J., Zhang, J., et al. (2011) · Journal of Clinical Oncology · doi:10.1200/jco.2011.29.15_suppl.3000 · Cited by 27
Systemic and Hepatosplanchnic Hemodynamic and Metabolic Effects of the PARP Inhibitor PJ34 During Hyperdynamic Porcine Endotoxemia
nyi, Z. I., Hauser, B. Z., Pittner, A., Asfar, P., Vassilev, D., Nalos, M., Altherr, J., ckner, U. B. B., Szabó, C., Radermacher, P., et al. (2003) · Shock · doi:10.1097/01.shk.0000048904.46342.22 · Cited by 26
The selective poly(ADP)ribose-polymerase 1 inhibitor INO1001 reduces spinal cord injury during porcine aortic cross-clamping-induced ischemia/reperfusion injury
Maier, C., Scheuerle, A., Hauser, B., Schelzig, H., Szabó, C., Radermacher, P., & Kick, J. (2007) · Intensive Care Medicine · doi:10.1007/s00134-007-0585-3 · Cited by 26
Poly(ADP-ribose) polymerase inhibition attenuates biventricular reperfusion injury after orthotopic heart transplantation☆
Szabo, G. B., Soós, P., Heger, U., Flechtenmacher, C., Bährle, S., Zsengellér, Z. K., Szabó, C., & Hagl, S. (2004) · European Journal of Cardio-Thoracic Surgery · doi:10.1016/j.ejcts.2004.10.055 · Cited by 26
Inhibition of poly (ADP-ribose) polymerase-1 enhances doxorubicin activity against liver cancer cells
Muñoz‐Gámez, J. A., Quiles, R., Ruiz‐Extremera, A., Martín-Álvarez, A. B., Sanjuán‐Nuñez, L., Carazo, A., León, J., Oliver, F. J., & Salmerón, J. (2010) · Cancer Letters · doi:10.1016/j.canlet.2010.10.026 · Cited by 25
Activation of Poly(ADP-Ribose) Polymerase in Circulating Leukocytes During Myocardial Infarction
Murthy, K. G. K., Xiao, C.-Y., Mabley, J. G., Chen, M., & Szabó, C. (2004) · Shock · doi:10.1097/01.shk.0000110621.42625.10 · Cited by 25
Genetic variation in DNA repair pathway genes and melanoma risk☆
Zhang, M., Qureshi, A. A., Guo, Q., & Han, J. (2010) · DNA repair · doi:10.1016/j.dnarep.2010.08.005 · Cited by 25
Poly(ADP-ribose) polymerase-1 inhibition increases expression of heat shock proteins and attenuates heat stroke-induced liver injury
Mota, R., Hernández‐Espinosa, D., Galbis‐Martínez, L., Ordóñez, A., Miñano, A., Parrilla, P., Vicente, V., Corral, J., & Yélamos, J. (2008) · Critical Care Medicine · doi:10.1097/01.ccm.0000299735.43699.e9 · Cited by 25
Role of Vitamin D in Parkinson’s Disease
Lương, K. V. Q., & Nguyễn, L. (2012) · ISRN Neurology · doi:10.5402/2012/134289 · Cited by 25
Pneumonia-Induced Sepsis and Gut Injury: Effects of a Poly-(ADP-Ribose) Polymerase Inhibitor
Lobo, S. M., Peres, S. O., Queiroz, M., Cunrath, G. S., Chibeni, G. S. A., Contrin, L. M., Cury, P. M., Burdmann, E. A., Machado, A. M. D. O., Togni, P., et al. (2005) · Journal of Surgical Research · doi:10.1016/j.jss.2005.05.018 · Cited by 25
Excessive stimulation of poly(ADP‐ribosyl)ation contributes to endothelial dysfunction in pre‐eclampsia
Crocker, I. P., Kenny, L. C., Thornton, W. A., Szabó, C., & Baker, P. N. (2005) · British Journal of Pharmacology · doi:10.1038/sj.bjp.0706055 · Cited by 24
Blood flow modification by nicotinamide and metoclopramide in mouse tumours growing in different sites
Hirst, D. G., Joiner, B., & Hirst, V. (1993) · British Journal of Cancer · doi:10.1038/bjc.1993.1 · Cited by 24
Increased Poly(ADP-Ribosyl)ation in Skeletal Muscle Tissue of Pediatric Patients with Severe Burn Injury
Oláh, G., Finnerty, C. C., Sbrana, E., Elijah, I. E., Gerő, D., Herndon, D. N., & Szabó, C. (2011) · Shock · doi:10.1097/shk.0b013e3182168d8f · Cited by 24
Quantification of Poly(ADP-Ribose)-Modified Proteins in Cerebrospinal Fluid from Infants and Children after Traumatic Brain Injury
Fink, E. L., Lai, Y., Zhang, X., Janesko‐Feldman, K. L., Adelson, P. D., Szabó, C., Berger, R. P., Sarnaik, A., Kochanek, P. M., & Clark, R. S. B. (2008) · Journal of Cerebral Blood Flow & Metabolism · doi:10.1038/jcbfm.2008.52 · Cited by 24
Modulation of the antiproliferative activity of anticancer drugs in hematopoietic tumor cell lines by the poly(ADP-ribose) polymerase inhibitor 6(5H)-phenanthridinone.
Holl, V., Coelho, D., Weltin, D., Hyun, J. W., Dufour, P., & Bischoff, P. (2000) · PubMed · Cited by 24
Neuroprotective effects of ONO-1924H, an inhibitor of poly ADP-ribose polymerase (PARP), on cytotoxicity of PC12 cells and ischemic cerebral damage
Kamanaka, Y., Kondo, K., Ikeda, Y., Kamoshima, W., Kitajima, T., Suzuki, Y., Nakamura, Y., & Umemura, K. (2004) · Life Sciences · doi:10.1016/j.lfs.2004.04.057 · Cited by 23
Molecular biological effects of selective neuronal nitric oxide synthase inhibition in ovine lung injury
Saunders, F., Westphal, M., Enkhbaatar, P., Wang, J., Pazdrak, K., Nakano, Y. Y., Hamahata, A., Jonkam, C., Lange, M., Connelly, R., et al. (2009) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00147.2009 · Cited by 23
Beneficial pulmonary effects of a metalloporphyrinic peroxynitrite decomposition catalyst in burn and smoke inhalation injury
Lange, M., Szabó, C., Enkhbaatar, P., Connelly, R., Horvath, E. M., Hamahata, A., Cox, R. A., Esechie, A., Nakano, Y. Y., Traber, L. D., et al. (2010) · American Journal of Physiology-Lung Cellular and Molecular Physiology · doi:10.1152/ajplung.00277.2010 · Cited by 23
Treatment with the PARP-inhibitor PJ34 causes enhanced doxorubicin-mediated cell death in HeLa cells
Magan, N., Isaacs, R. J., & Stowell, K. M. (2012) · Anti-Cancer Drugs · doi:10.1097/cad.0b013e328350900f · Cited by 23
The Ala Allele at Val762Ala Polymorphism in Poly(ADP-ribose) Polymerase-1 (PARP-1) Gene is Associated with a Decreased Risk of Asthma in a Turkish Population
Tezcan, G., Gurel, C. B., Tutluoğlu, B., Onaran, İ., & Sultuybek, G. K. (2009) · Journal of Asthma · doi:10.1080/02770900902777791 · Cited by 22
Relationship between NADPH oxidase p22phox C242T, PARP-1 Val762Ala polymorphisms, angiographically verified coronary artery disease and myocardial infarction in South Indian patients with type 2 diabetes mellitus
Narne, P., Ponnaluri, K. C., Singh, S., Mohammed, S., & Ishaq, M. (2012) · Thrombosis Research · doi:10.1016/j.thromres.2012.09.012 · Cited by 22
Leu54Phe and Val762Ala polymorphisms in the poly(ADP-ribose)polymerase-1 gene are associated with diabetic polyneuropathy in Russian type 1 diabetic patients
Nikitin, A. G., Chudakova, D. A., Strokov, I. A., Bursa, T. R., Chistiakov, D. A., & Nosikov, V. V. (2007) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2007.10.020 · Cited by 22
INHIBITION OF POLY(ADP-RIBOSE) SYNTHETASE IMPROVES VASCULAR CONTRACTILE RESPONSES FOLLOWING TRAUMA-HEMORRHAGE AND RESUSCITATION
John, J., Barbee, R. W., Sonin, N. V., Clemens, M. G., & Watts, J. A. (1999) · Shock · doi:10.1097/00024382-199909000-00004 · Cited by 22
Transcriptional Regulation of the Human Inducible Nitric Oxide Synthase Gene in an Intestinal Epithelial Cell Line † 127
Morelli, P. J., Linn, S. C., Edry, I., Cottingim, S. E., Szabó, C., & Salzman, A. L. (1997) · Pediatric Research · doi:10.1203/00006450-199704001-00147 · Cited by 22
PARP-1 Val762Ala polymorphism is associated with reduced risk of non-Hodgkin lymphoma in Korean males
Jin, X. M., Kim, H. N., Lee, I.-K., Park, K.-S., Kim, H., Choi, J., Juhng, S. W., & Choi, C. (2010) · BMC Medical Genetics · doi:10.1186/1471-2350-11-38 · Cited by 22
Glial reactions and degeneration of myelinated processes in spinal cord gray matter in chronic experimental autoimmune encephalomyelitis
Wu, J., Ohlsson, M., Warner, E. A., Loo, K. K., Hoang, T. X., Voskuhl, R. R., & Havton, L. A. (2008) · Neuroscience · doi:10.1016/j.neuroscience.2008.07.037 · Cited by 21
Doxorubicin-induced suppression of poly(ADP-ribose) polymerase-1 (PARP-1) activity and expression and its implication for PARP inhibitors in clinical trials
Zaremba, T., Thomas, H. D., Cole, M. F., Plummer, E. R., & Curtin, N. J. (2010) · Cancer Chemotherapy and Pharmacology · doi:10.1007/s00280-010-1359-0 · Cited by 21
Self-citation
Increased poly(ADP-ribose) polymerase (PARP)-1 expression and activity are associated with inflammation but not goblet cell metaplasia in murine models of allergen-induced airway inflammation
Havranek, T., Aujla, P. K., Nickola, T. J., Rose, M. C., & Scavo, L. M. (2010) · Experimental Lung Research · doi:10.3109/01902141003663360 · Cited by 21
Protective effect of cardioplegia with poly (ADP-ribose) polymerase-1 inhibitor against myocardial ischemia-reperfusion injury: in vitro study of isolated rat heart model
Yamazaki, K., Tanaka, S., Sakata, R., Miwa, S., Oriyanhan, W., Takaba, K., Minakata, K., Marui, A., Ikeda, T., Toyokuni, S., et al. (2011) · Journal of Enzyme Inhibition and Medicinal Chemistry · doi:10.3109/14756366.2011.642373 · Cited by 20
A Novel and Orally Active Poly(ADP-Ribose) Polymerase Inhibitor, KR-33889 [2-[Methoxycarbonyl(4-methoxyphenyl) methylsulfanyl]-1 H-benzimidazole-4-carboxylic Acid Amide], Attenuates Injury in in Vitro Model of Cell Death and in Vivo Model of Cardiac Ischemia
Oh, K., Lee, S., Yi, K. Y., Seo, H. W., Koo, H., & Lee, B. H. (2008) · Journal of Pharmacology and Experimental Therapeutics · doi:10.1124/jpet.108.143719 · Cited by 20
Poly(ADP-ribose) Polymerase Activation and Cell Injury in the Course of Rat Heart Heterotopic Transplantation
Fiorillo, C., Pace, S., Ponziani, V., Nediani, C., Perna, A., Liguori, P., Cecchi, C., Nassi, N., Donzelli, G., Formigli, L., et al. (2002) · Free radical research · doi:10.1080/10715760210168 · Cited by 20
Traumatic Brain Injury in Mice Deficient in Poly-ADP(Ribose) Polymerase: A Preliminary Report
Whalen, M. J., Clark, R. S. B., Dixon, C. E., Robichaud, P., Marion, D. W., Vagni, V., Graham, S. H., Virág, L., Haskó, G., Stachlewitz, R. F., et al. (2000) · Springer eBooks · doi:10.1007/978-3-7091-6346-7_12 · Cited by 19
Tamoxifen, esterified estradiol, and physiologic concentrations of estradiol inhibit oxidation of low-density lipoprotein by endothelial cells
Kuohung, W., Shwaery, G. T., & Keaney, J. F. (2001) · American Journal of Obstetrics and Gynecology · doi:10.1067/mob.2001.115229 · Cited by 19
Poly (ADP) Ribose Polymerase Inhibition Improves Rat Cardiac Allograft Survival
Farivar, A. S., McCourtie, A. S., Patterson, B. M., Woolley, S. M., Barnes, A. D., Chen, M., Jagtap, P. G., Szabó, C., Salerno, C. T., & Mulligan, M. S. (2005) · The Annals of Thoracic Surgery · doi:10.1016/j.athoracsur.2005.02.035 · Cited by 19
Poly (ADP-Ribose) Polymerase as a Potential Target for the Treatment of Acute Renal Injury Caused by Lipopolysaccharide
Taşatargil, A., Aksoy, N. H., Dalaklıoğlu, S., & Şadan, G. (2008) · Renal Failure · doi:10.1080/08860220701742195 · Cited by 18
Increased transcript level of poly(ADP-ribose) polymerase (PARP-1) in human tricuspid compared with bicuspid aortic valves correlates with the stenosis severity
Nagy, E., Caidahl, K., Franco‐Cereceda, A., & Bäck, M. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.03.064 · Cited by 18
Transient perfusion and radiosensitizing effect after nicotinamide, carbogen, and perflubron emulsion administration
Thomas, C. D., Stern, S., Chaplin, D. J., & Guichard, M. (1996) · Radiotherapy and Oncology · doi:10.1016/0167-8140(96)01734-3 · Cited by 18
DNA repair, ADP-ribosylation and pyridine nucleotide metabolism as targets for cancer chemotherapy.
Berger, N. A., Berger, S. J., & Gerson, S. L. (1987) · PubMed · Cited by 18
Neuroprotective effects of KCL-440, a new poly(ADP-ribose) polymerase inhibitor, in the rat middle cerebral artery occlusion model
Ikeda, Y., Hokamura, K., Kawai, T., Ishiyama, J., Ishikawa, K., Anraku, T., Uno, T., & Umemura, K. (2005) · Brain Research · doi:10.1016/j.brainres.2005.08.046 · Cited by 17
Phase I safety and pharmacokinetic (PK) study of veliparib in combination with whole brain radiation therapy (WBRT) in patients (pts) with brain metastases.
Mehta, M. P., Curran, W. J., Wang, D., Wang, F., Kleinberg, L. R., Brade, A. M., Mostafa, N. M., Zhou, X., Qian, J. X., Leahy, T., et al. (2012) · Journal of Clinical Oncology · doi:10.1200/jco.2012.30.15_suppl.2013 · Cited by 17
Inhibitors of poly (ADP-ribose) polymerase ameliorate myocardial reperfusion injury by modulation of activator protein-1 and neutrophil infiltration.
Kaplan, J. M., O’Connor, M. P., Hake, P. W., & Zingarelli, B. (2005) · PubMed · Cited by 14
Inhibition of poly(ADP-ribose) polymerase prevents vascular hyporesponsiveness induced by lipopolysaccharide in isolated rat aorta
Taşatargil, A., Dalaklıoğlu, S., & Şadan, G. (2005) · Pharmacological Research · doi:10.1016/j.phrs.2005.02.020 · Cited by 14
Evaluation of the poly(ADP-ribose) polymerase gene in human stroke
Kato, N., Morita, H., Sugiyama, T., Kurihara, H., Tsubaki, S.-I., Nabika, T., Kitamura, K., Yamori, Y., & Yazaki, Y. (2000) · Atherosclerosis · doi:10.1016/s0021-9150(99)00284-1 · Cited by 14
Improved Poststorage Cardiac Function by Poly (ADP-ribose) Polymerase Inhibition: Role of Phosphatidylinositol 3-Kinase Akt Pathway
Gao, L., Kwan, J., Macdonald, P. S., Yang, L., Preiß, T., & Hicks, M. (2007) · Transplantation · doi:10.1097/01.tp.0000276924.08343.78 · Cited by 14
Inhibition of poly(ADP-ribose) polymerase inhibits ischemia/reperfusion induced neurodegeneration in retina via suppression of endoplasmic reticulum stress
Li, C., Wang, L., Kern, T. S., & Zheng, L. (2012) · Biochemical and Biophysical Research Communications · doi:10.1016/j.bbrc.2012.05.109 · Cited by 14
Poly[ADP-Ribose] Polymerase-1 Expression Is Related To Cold Ischemia, Acute Tubular Necrosis, and Delayed Renal Function In Kidney Transplantation
O’Valle, F., Moral, R. G.-D., Benítez, M. D. C., Martín‐Oliva, D., Gómez‐Morales, M., Aguilar, D., Aneiros‐Fernández, J., Hernández‐Cortés, P., Osuna, A., Moreso, F., et al. (2009) · PLoS ONE · doi:10.1371/journal.pone.0007138 · Cited by 14
Nicotinamide Relaxes Vascular Smooth Muscle by Inhibiting Myosin Light Chain Kinase-Dependent Signaling Pathways: Implications for Anticancer Efficacy
Ruddock, M. W., & Hirst, D. G. (2004) · Oncology Research Featuring Preclinical and Clinical Cancer Therapeutics · doi:10.3727/0965040042380478 · Cited by 14
The Angiotensin-Converting Enzyme Inhibitor Captopril Inhibits Poly(Adp-Ribose) Polymerase Activation and Exerts Beneficial Effects in an Ovine Model of Burn and Smoke Injury
Asmussen, S., Bartha, É., Oláh, G., Sbrana, E., Rehberg, S. W., Yamamoto, Y., Enkhbaatar, P., Hawkins, H. K., Ito, H., Cox, R. A., et al. (2011) · Shock · doi:10.1097/shk.0b013e318228f614 · Cited by 13
Poly(ADP-Ribose) Polymerase Inhibition Improves Erectile Function by Activation of Nitric Oxide/Cyclic Guanosine Monophosphate Pathway in Diabetic Rats
Li, W. J., Peng, Y., Zhou, J., Li, B., Wang, H., Zhang, J., & Wang, Z. (2012) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2012.02666.x · Cited by 13
Immunomodulatory Effects of Poly(ADP-ribose) Polymerase Inhibition Contribute to Improved Cardiac Function and Survival During Acute Cardiac Rejection
Szabo, G. B., Bährle, S., Sivanandam, V., Stumpf, N., Gerő, D., Berger, I., Beller, C. J., Hagl, S., Szabó, C., & Dengler, T. J. (2006) · The Journal of Heart and Lung Transplantation · doi:10.1016/j.healun.2006.03.017 · Cited by 12
Burn and Smoke Injury Activates Poly(ADP-ribose)polymerase in Circulating Leukocytes
Bartha, É., Asmussen, S., Oláh, G., Rehberg, S. W., Yamamoto, Y., Traber, D. L., & Szabó, C. (2011) · Shock · doi:10.1097/shk.0b013e318212988c · Cited by 12
Administration of poly(ADP-ribose) polymerase inhibitor into bronchial artery attenuates pulmonary pathophysiology after smoke inhalation and burn in an ovine model
Hamahata, A., Enkhbaatar, P., Lange, M., Yamaki, T., Sakurai, H., Shimoda, K., Nakazawa, H., Traber, L. D., & Traber, D. L. (2012) · Burns · doi:10.1016/j.burns.2012.08.021 · Cited by 12
Poly (adp-ribose) synthetase inhibition reduces oxidative and nitrosative organ damage after thermal injury
Avlan, D., Ünlü, A., Ayaz, L., Ankaralı, H. Ç., Naycı, A., & Aksöyek, S. (2005) · Pediatric Surgery International · doi:10.1007/s00383-005-1409-6 · Cited by 11
PARP1 Polymorphisms Increase the Risk of Gastric Cancer in a Chinese Population
He, W., Liu, T., Shan, Y., Zhu, K., & Li, Y. (2012) · Molecular Diagnosis & Therapy · doi:10.1007/bf03256428 · Cited by 11
Climbing STAIRs towards clinical trials with a novel PARP-1 inhibitor for the treatment of ischemic stroke
Ford, A. L., & Lee, J. (2011) · Brain Research · doi:10.1016/j.brainres.2011.07.001 · Cited by 11
Effects of Inhibition of Poly(Adenosine Diphosphate-Ribose) Synthase on Acute Cardiac Allograft Rejection
Liu, Y., Son, N. H., Szabolcs, M. J., Ma, N., Sciacca, R. R., Albala, A., Edwards, N. M., & Cannon, P. (2004) · Transplantation · doi:10.1097/01.tp.0000131662.01491.2e · Cited by 11
Chemical Approaches to Improved Radiotherapy
Leopold, W. R., & Sebolt–Leopold, J. S. (1992) · Springer eBooks · doi:10.1007/978-1-4615-3492-1_9 · Cited by 10
Poly(ADP-Ribose) Polymerase Inhibition Reverses Nitrergic Neurovascular Dysfunctions in Penile Erectile Tissue from Streptozotocin-Diabetic Mice
Nangle, M. R., Cotter, M. A., & Cameron, N. E. (2010) · The Journal of Sexual Medicine · doi:10.1111/j.1743-6109.2010.01835.x · Cited by 10
The Val762Ala polymorphism in the poly(ADP-ribose) polymerase-1 gene is not associated with susceptibility in Turkish rheumatoid arthritis patients
Onaran, İ., Tezcan, G., Özgönenel, L., Çetin, E., Özdemir, A. T., & Sultuybek, G. K. (2008) · Rheumatology International · doi:10.1007/s00296-008-0772-8 · Cited by 10
Contractile properties of human renal cell carcinoma recruited arteries and their response to nicotinamide
Ruddock, M. W., Burns, D., McKEOWN, S. R., Murphy, L., Walsh, I. K., Keane, P. F., & Hirst, D. G. (2000) · Radiotherapy and Oncology · doi:10.1016/s0167-8140(99)00163-2 · Cited by 9
Lack of association between Poly(ADP-ribose) polymerase (PARP) polymorphisms and rheumatoid arthritis in a Korean population
Lee, K.-A., Bang, S., Park, B. L., Kim, J., Shin, H. D., & Bae, S. (2010) · Rheumatology International · doi:10.1007/s00296-010-1589-9 · Cited by 9
Metformin suppresses high glucose–induced poly(adenosine diphosphate–ribose) polymerase overactivation in aortic endothelial cells
Mahrouf‐Yorgov, M., Marie, N., Borderie, D., Djelidi, R., Bonnefont‐Rousselot, D., Legrand, A., Beaudeux, J., & Peynet, J. (2009) · Metabolism · doi:10.1016/j.metabol.2008.11.012 · Cited by 9
Increased Poly(ADP-Ribosyl)ation in Peripheral Leukocytes and the Reperfused Myocardium Tissue of Rats With Ischemia/Reperfusion Injury
Zhang, L., Qi, G., Jiang, D., Tian, W., & Zou, J. (2012) · Shock · doi:10.1097/shk.0b013e31824989d7 · Cited by 9
Association analysis of PARP1 polymorphisms with Parkinson’s disease
Brighina, L., Riva, C., Bertola, F., Fermi, S., Saracchi, E., Piolti, R., Goldwurm, S., Pezzoli, G., & Ferrarese, C. (2011) · Parkinsonism & Related Disorders · doi:10.1016/j.parkreldis.2011.06.022 · Cited by 8
Brain Ischemic Preconditioning Does Not Require PARP-1
Faraco, G., Blasi, F., Min, W., Wang, Z., Moroni, F., & Chiarugi, A. (2009) · Stroke · doi:10.1161/strokeaha.109.567826 · Cited by 8
Ischemic and inflammatory lung impairment by extracorporeal circulation: Effect of PARP-inhibition by INO1001
Dhein, S., KRAUSE, N., Ullmann, C., Flister, A., Lehmann, S., Muth, P., Walther, T., Kostelka, M., & Mohr, F. W. (2008) · Pharmacological Research · doi:10.1016/j.phrs.2008.09.009 · Cited by 8
Increased poly(ADP-ribose) polymerase activity during porcine hemorrhagic shock is transient and predictive of mortality
Skarda, D. E., Putt, K. S., Hergenrother, P. J., Mulier, K. E., & Beilman, G. J. (2007) · Resuscitation · doi:10.1016/j.resuscitation.2007.02.020 · Cited by 8
Contractile dysfunction in experimental cardiac allograft rejection: role of the poly (ADP-ribose) polymerase pathway*
Szabo, G. B., Bährle, S., Stumpf, N., Szabó, C., & Hagl, S. (2006) · Transplant International · doi:10.1111/j.1432-2277.2005.00262.x · Cited by 7
Poly(ADP-Ribose) Polymerase Expression in Kidney Transplantation: From Alfa (α) to Omega (Ω)
O’Valle, F., Gómez‐Morales, M., Moral, R. M. G. D., Serón, D., Moreso, F., Osuna, A., Oliver, F. J., & del Moral, R. G. (2007) · Transplantation Proceedings · doi:10.1016/j.transproceed.2007.07.075 · Cited by 7
POLY-ADP RIBOSYL SYNTHETASE INHIBITION REVERSES VASCULAR HYPOREACTIVITY IN SEPTIC MICE
Osman, J., Jablon, S., Parrillo, N., Easington, C. R., Parrillo, J. E., & Hollenberg, S. (1998) · Critical Care Medicine · doi:10.1097/00003246-199801001-00408 · Cited by 6
No associations of polymorphisms in ADPRT with hepatitis B virus clearance and hepatocellular carcinoma occurrence in a Korean population
Lee, J. S., Kim, J., Park, B., Cheong, H. S., Koh, I., Kim, J. Y., Park, T. J., Pasaje, C. F. A., Bae, J. S., Lee, H.-S., et al. (2011) · Hepatology Research · doi:10.1111/j.1872-034x.2010.00772.x · Cited by 3
Polymorphic markers Val762Ala and Leu54Phe of the ADPRT1 gene associated with chronic glomerulonephritis in Russian patients from Moscow
Шестаков, А. Е., Kamyshova, E. S., Константиновна, П. Э., Kutyrina, I. M., Savostyanov, K. V., & Nosikov, V. V. (2007) · Russian Journal of Genetics · doi:10.1134/s1022795407020159 · Cited by 2
Increased activity of surviving locus ceruleus neurons in Alzheimer's disease
Moser (1999) · Pure Amsterdam UMC · doi:10.1002/1531-8249(199901)45:1

Flagged first, then by citations

8 of the 559 references couldn’t be matched to a known paper.

Research works printed but not linked: 3

Du, 2007, Local administration of the poly (ADP-ribose) polymerase inhibitor INO-1001 prevents NAD+ depletion and improves water maze performance after traumatic brain injury in mice, J. Neurotrauma, 24, 1399, 10.1089/neu.2007.0305 · DOI
Komjáti, 2005, Poly(ADP-ribose) polymerase inhibitors as therapeutic agents for stroke and brain trauma. Current Drug Targets, CNS Neurol. Disord., 4, 179
Miknyoczki, 2003, Chemopotentiation of temozlomide, irinotecan and cisplatin activity by CEP-6800, a poly(ADP-ribose) polymerase inhibitor, Mol. Cancer Ther., 2, 371

Sorted by citations

Molecular mechanisms of cell death: recommendations of the nomenclature committee on cell death 2018.
Galluzzi, L., Vitale, I., Aaronson, S. A., Abrams, J. M., Adam, D., Agostinis, P., Alnemri, E. S., Altucci, L., Amelio, I., Andrews, D. W., et al. (2018) · Cell Death & Differentiation · doi:10.1038/s41418-017-0012-4 · Cited by 6,680
Regulated necrosis: the expanding network of non-apoptotic cell death pathways
Berghe, T. V., Linkermann, A., Jouan-Lanhouet, S., Walczak, H., & Vandenabeele, P. (2014) · Nature Reviews Molecular Cell Biology · doi:10.1038/nrm3737 · Cited by 1,735
NAD+ Metabolism and the Control of Energy Homeostasis: A Balancing Act between Mitochondria and the Nucleus
Cantó, C., Menzies, K. J., & Auwerx, J. (2015) · Cell Metabolism · doi:10.1016/j.cmet.2015.05.023 · Cited by 1,648
Kynurenine pathway of tryptophan metabolism: regulatory and functional aspects
Badawy, A. A.-B. (2017) · International Journal of Tryptophan Research · doi:10.1177/1178646917691938 · Cited by 1,158
Essential versus accessory aspects of cell death: recommendations of the NCCD 2015
Galluzzi, L., Bravo-San Pedro, J. M., Vitale, I., Aaronson, S. A., Abrams, J. M., Adam, D., Alnemri, E. S., Altucci, L., Andrews, D., Annicchiarico-Petruzzelli, M., et al. (2015) · Cell Death & Differentiation · doi:10.1038/cdd.2014.137 · Cited by 1,002

See all 391

Authors: Curtin, N. J., & Szabo, C.
Affiliations: Newcastle University (GB)
Corresponding author: Curtin, Nicola J.
ORCID: Curtin, Nicola J.
Venue: Molecular Aspects of Medicine
Publisher: Elsevier BV
Published: 2013-12
Volume: 34
Issue: 6
Pages: 1217-1256
ISSN: 0098-2997 (ISSN-L)
DOI: 10.1016/j.mam.2013.01.006
PMC: PMC3657315
OpenAlex: W2017171454
Cited by: 369
References: 559
Citations by year: 2026: 9 · 2025: 17 · 2024: 12 · 2023: 22 · 2022: 25 · 2021: 25 · 2020: 37 · 2019: 31 · 2018: 26 · 2017: 32 · 2016: 38 · 2015: 50 · 2014: 24 · 2013: 21
FWCI: 4.93
Type: journal article
Language: en
Open access: green
www.ncbi.nlm.nih.gov
Licence: www.elsevier.com/tdm/userlicense/1.0/ (tdm)
www.elsevier.com/legal/tdmrep-license (tdm)
Locations: Molecular Aspects of Medicine (publishedVersion)
PubMed (publishedVersion)
PubMed Central (acceptedVersion)
Newcastle University ePrints (Newcastle Univesity)
Funders: National Institutes of Health
Topics: Health Sciences › Medicine › Oncology › PARP inhibition in cancer therapy
Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › DNA Repair Mechanisms
Life Sciences › Biochemistry, Genetics and Molecular Biology › Genetics › BRCA gene mutations in cancer
Keywords: PARP inhibitors, poly(ADP-ribose) polymerase, synthetic lethality, homologous recombination deficiency, BRCA mutations, breast cancer, ovarian cancer, temozolomide combination therapy, topoisomerase inhibitors, ionizing radiation, oxidative stress, nitrative stress, necrosis, inflammation, stroke, neurotrauma, shock, acute myocardial infarction, clinical translation
MeSH terms: Poly(ADP-ribose) Polymerase Inhibitors, Animals, Antineoplastic Agents, Cardiovascular Diseases, Clinical Trials as Topic, Enzyme Inhibitors, Humans, Neoplasms, Poly(ADP-ribose) Polymerases, Radiation-Sensitizing Agents, Stroke, Translational Research, Biomedical, Molecular Targeted Therapy

About these checks

Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.

Statistics and arithmetic are recomputed, not judged.

Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.

What counts as a claim ›How we measure confidence ›How we check this ›

Are you an author, or do you see a problem with this page? Request a review

Therapeutic applications of PARP inhibitors: Anticancer therapy and beyond

Abstract

Overview

Integrity signals

Verification

Claims the paper makes

Claims other papers make about this one

Self-check

Citations

Cites

Cited by

Related

Metadata

Record

About these checks